Medical note: This article is for educational purposes only and is not a substitute for professional medical advice. Sirturo is a prescription tuberculosis medicine that should be used only under the direction of a qualified healthcare provider, usually with close monitoring and directly observed therapy.
What Is Sirturo (bedaquiline)?
Sirturo, the brand name for bedaquiline, is an antimycobacterial prescription medicine used to treat certain hard-to-treat forms of tuberculosis, often called TB. Unlike the old “take two pills and call me in the morning” fantasy, tuberculosis treatment is more like assembling a serious medical task force. Sirturo is one member of that team, not a solo superhero with a cape and a dramatic soundtrack.
Bedaquiline belongs to a class called diarylquinoline antimycobacterial drugs. It works by interfering with the energy production system of Mycobacterium tuberculosis, the bacteria that causes TB. In plain English: it targets the bacteria’s power supply. No power, no party.
Sirturo is used as part of combination therapy for adults and children 2 years and older who weigh at least 8 kg and have pulmonary tuberculosis caused by M. tuberculosis resistant to at least rifampin and isoniazid. Those two drugs are among the most important first-line TB medicines, so resistance to them makes treatment more complicated and more serious.
Sirturo Uses: What Is It Prescribed For?
The main approved use of Sirturo is for pulmonary drug-resistant tuberculosis. “Pulmonary” means the infection is in the lungs. “Drug-resistant” means the TB bacteria are not controlled by certain standard medicines. Sirturo is not used casually, and it is not prescribed for a stubborn cough that refuses to leave like an unwanted houseguest.
Sirturo may be used for:
- Adults with pulmonary TB resistant to rifampin and isoniazid
- Children 2 years and older weighing at least 8 kg with eligible drug-resistant pulmonary TB
- Combination regimens designed by TB specialists based on drug susceptibility testing
- All-oral drug-resistant TB regimens in selected patients, depending on national guidance and individual clinical factors
Sirturo is not intended for:
- Latent TB infection, where TB bacteria are present but not causing active disease
- Drug-sensitive TB that can be treated with standard first-line therapy
- Extrapulmonary TB, meaning TB outside the lungs
- Infections caused by non-tuberculous mycobacteria
This distinction matters because using bedaquiline incorrectly can encourage resistance. In TB care, resistance is the villain that keeps coming back for the sequel. The goal is to use Sirturo carefully, with enough companion drugs, so the bacteria do not learn how to dodge it.
How Sirturo Works
Sirturo blocks mycobacterial ATP synthase, an enzyme the TB bacteria need to produce energy. Think of ATP as the bacteria’s battery pack. Bedaquiline jams the charger. Over time, this helps weaken and kill the bacteria when used with other effective TB medicines.
Because TB bacteria are notoriously tough and slow-growing, treatment is not instant. Patients often feel better before the infection is fully controlled, which can make skipping doses tempting. That is a bad idea. Stopping early or missing doses can reduce treatment success and increase the risk that TB becomes even harder to treat.
Sirturo Dosing: How Is Bedaquiline Taken?
Sirturo dosing depends on age, body weight, treatment plan, and medical supervision. It is typically given by directly observed therapy, meaning a healthcare worker or trained person helps confirm that doses are taken correctly. This is not because doctors enjoy being bossy; it is because TB treatment failure can have serious consequences for the patient and the community.
Typical adult dosing
For adults, the commonly recommended Sirturo schedule is:
- Weeks 1 and 2: 400 mg by mouth once daily with food
- Weeks 3 through 24: 200 mg by mouth three times per week with food, with at least 48 hours between doses
The total standard course is 24 weeks, although certain treatment regimens may require specialist decisions about longer use. Never extend, shorten, or restart Sirturo without medical guidance.
Pediatric dosing
For children 2 years and older weighing at least 8 kg, dosing is based on body weight. Pediatric dosing should be calculated by a healthcare provider, not guessed at the kitchen table beside a spoon, a calculator, and rising panic.
Children may receive 20 mg tablets, which can be split, dispersed in water, mixed with certain soft foods or beverages, or administered through a feeding tube when directed by a healthcare professional. The 100 mg tablet should generally be swallowed whole with water.
Take Sirturo with food
Sirturo should be taken with food because food improves absorption. In other words, the medicine gets into the body better when it is not arriving alone to an empty stomach party.
Missed Dose Instructions
Missed-dose instructions depend on where the patient is in treatment.
During Weeks 1 and 2
If a dose is missed during the first two weeks, the patient should usually skip the missed dose and take the next dose at the regular time. Do not double up unless a healthcare provider specifically says to do so.
During Weeks 3 through 24
If a dose is missed from Week 3 onward, the patient may be instructed to take the missed dose as soon as possible and then continue the three-times-weekly schedule. There should be enough time between doses, and the total weekly dose should not exceed the prescribed amount.
Because Sirturo is part of a larger TB regimen, missed doses should be reported to the TB care team. Silence may be golden in libraries, but not in drug-resistant TB treatment.
Sirturo Side Effects
Like all powerful medicines, Sirturo can cause side effects. Some are manageable; others require urgent medical attention. Because patients take Sirturo with other TB medicines, it can sometimes be difficult to know which drug is causing which symptom. That is why regular monitoring matters.
Common side effects
- Nausea
- Vomiting
- Joint pain
- Headache
- Rash or itching
- Abdominal pain
- Dizziness
- Chest pain
- Dry skin
- Trouble sleeping
- Palpitations or a pounding heartbeat
- Increased liver enzymes on blood tests
Serious side effects
Patients should contact a healthcare provider immediately or seek urgent care if they experience symptoms such as fainting, severe dizziness, fast or irregular heartbeat, yellowing of the skin or eyes, dark urine, pale stools, severe fatigue, persistent vomiting, chest pain, or coughing up blood.
Major Warnings for Sirturo
QTc prolongation and heart rhythm risk
Sirturo has a boxed warning for QTc prolongation, a change in the heart’s electrical rhythm that can become dangerous. Healthcare providers usually check an ECG before treatment and during treatment. Blood levels of potassium, calcium, and magnesium may also be checked because abnormal electrolytes can increase heart rhythm risk.
The risk may be higher in people with a history of long QT syndrome, certain heart rhythm disorders, heart failure, slow heart rate, low electrolytes, or use of other QT-prolonging medicines.
Liver toxicity
Sirturo can be associated with liver-related side effects, especially when combined with other TB medicines that can also affect the liver. Healthcare providers usually check liver enzymes before treatment and regularly during therapy.
Patients should avoid alcohol during treatment. Alcohol and TB medicines are not a charming cocktail; they are more like two bad roommates fighting inside the liver.
Mortality imbalance in clinical trials
Earlier clinical trial data showed an unexplained imbalance in deaths among patients receiving Sirturo compared with placebo in one study. Later studies and modern regimens have added more context, but the warning remains important. Sirturo should be used only when the expected benefits justify the risks and when the patient can be monitored appropriately.
Resistance risk
Bedaquiline should never be used by itself for TB. It must be combined with other active TB medicines. Using it alone is like sending one firefighter to a warehouse fire with a coffee mug full of water.
Sirturo Drug Interactions
Sirturo has important drug interaction concerns, especially with medicines that affect the CYP3A4 enzyme or prolong the QT interval.
CYP3A4 inducers
Moderate or strong CYP3A4 inducers can lower bedaquiline levels and may reduce its effectiveness. Examples include rifampin, rifapentine, rifabutin, and efavirenz. These combinations are generally avoided unless a specialist determines otherwise.
CYP3A4 inhibitors
CYP3A4 inhibitors can increase bedaquiline exposure, which may increase the risk of side effects. Examples may include certain azole antifungals, macrolide antibiotics, and some HIV medications. Monitoring may be needed.
QT-prolonging medicines
Combining Sirturo with other medicines that prolong QT interval can raise heart rhythm risk. This may include certain antibiotics, antipsychotics, antidepressants, antiarrhythmics, and TB drugs such as clofazimine or fluoroquinolones. Because drug interaction lists can be long, patients should give their healthcare team a complete list of prescription medicines, over-the-counter drugs, vitamins, and herbal supplements.
What Does Sirturo Look Like? Pictures and Tablet Description
Sirturo comes as tablets. The 20 mg tablet is white to almost white, oblong, and functionally scored, with “2” and “0” debossed on one side. The 100 mg tablet is white to almost white, round, and biconvex, with “T” over “207” on one side and “100” on the other.
Patients should not rely only on online pill pictures to identify medication. Tablets can look different because of formulation updates, packaging differences, or pharmacy handling. If a pill looks unfamiliar, ask a pharmacist before taking it. Your pharmacist has seen enough pills to qualify as a tiny tablet detective.
Who Should Be Careful Before Taking Sirturo?
Before starting Sirturo, patients should tell their healthcare provider if they have heart rhythm problems, long QT syndrome, liver disease, severe kidney disease, HIV, thyroid problems, low potassium or magnesium, pregnancy, plans to become pregnant, or breastfeeding.
Breastfeeding is generally not recommended during Sirturo treatment and for a long period after the last dose unless infant formula is not available, because bedaquiline can accumulate in breast milk and may pose risks to the infant.
Monitoring During Sirturo Treatment
Monitoring is a major part of safe bedaquiline treatment. A typical care plan may include:
- ECG before and during treatment
- Potassium, calcium, and magnesium blood tests
- Liver enzyme tests before treatment and monthly during therapy
- Medication review for QT and CYP3A4 interactions
- TB culture and susceptibility testing when available
- Regular adherence support through directly observed therapy
Practical Experience: What Patients and Caregivers Often Notice During Sirturo Treatment
Living through drug-resistant TB treatment is not just a medication schedule; it is a lifestyle interruption with a clipboard. Patients may have appointments, lab tests, ECGs, public health check-ins, side effect discussions, and a medicine routine that feels like it deserves its own calendar app. Sirturo can be a valuable part of treatment, but success depends heavily on consistency, communication, and support.
One common experience is that the treatment plan feels intense at the beginning. The first two weeks involve daily dosing, and patients may also be adjusting to several other TB medicines. Nausea, fatigue, appetite changes, or general “I do not feel like myself” days can happen. This is when practical habits matter. Taking Sirturo with food, keeping a symptom journal, and reporting side effects early can make treatment safer and more manageable.
Another real-world issue is anxiety around ECG monitoring. Hearing that a medicine can affect heart rhythm can sound scary, but monitoring is designed to catch problems early. Patients should not ignore symptoms like fainting, sudden dizziness, or a racing heartbeat. At the same time, they should not panic simply because an ECG is ordered. In TB care, an ECG is often a safety seatbelt, not a crash alarm.
Caregivers often play an important role, especially for children or adults dealing with fatigue. They may help organize appointments, prepare food before dosing, track missed doses, and notice symptoms the patient might minimize. A caregiver can also help the patient avoid alcohol and check with the medical team before adding supplements or over-the-counter medicines.
Patients also sometimes struggle emotionally. Drug-resistant TB can feel isolating because treatment is long and public health precautions may affect work, school, family routines, and social life. Encouragement matters. So does plain communication with the TB team. If side effects are making adherence difficult, the answer is not to quietly stop; the answer is to tell the care team quickly. Many problems can be managed, but only if the team knows they exist.
Food routines can help. Since Sirturo should be taken with food, patients often do better when they link dosing to a reliable meal or snack. Something simple and tolerated is better than an ambitious “perfect health breakfast” that nobody wants at 7 a.m. during nausea week. The best plan is the one the patient can actually follow.
Finally, the biggest experience-based lesson is this: completion matters. Drug-resistant TB treatment is a marathon wearing hiking boots. Some days are annoying, some are boring, and some are genuinely hard. But taking the full regimen as prescribed gives the best chance of cure and helps prevent TB bacteria from becoming even more resistant.
Conclusion
Sirturo (bedaquiline) is an important medicine for certain forms of pulmonary drug-resistant tuberculosis. It can help treat TB when standard medicines are not enough, but it must be used carefully, always with other effective TB drugs, and with close medical monitoring. The major safety issues include QTc prolongation, liver toxicity, drug interactions, and the risk of resistance if treatment is not taken correctly.
For patients, the most important takeaways are simple: take Sirturo exactly as prescribed, take it with food, do not skip doses, avoid alcohol, report side effects quickly, and keep every monitoring appointment. TB treatment may not be glamorous, but done correctly, it can be life-changing. And honestly, beating drug-resistant bacteria is far more impressive than remembering where you put your car keys.
